Skip to main content
TipRanks
Go Ultimate75% OFF

CVS Health (0HRS) Share Price & Analysis

4 Followers

0HRS Stock Chart & Stats

$86.32-$1.94(-2.20%)
At close: 4:30 PM GMT
$80$85$90$95Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$84.74 - $89.17
52-Week Range
$69.18 - $112.00
Previous Close
$88.26
Volume
N/A
Average Volume (3M)
8,291
Market Cap
$109.79B
Enterprise Value
$171.23B
Total Cash (Recent Filing)
$14.89B
Total Debt (Recent Filing)
$75.30B
Price to Earnings (P/E)
9.9
Beta
0.59
Next Earnings
Feb 17, 2027 (Est.)
Dividend Yield
3.08%

Bulls Say, Bears Say

Bulls Say

Integrated Healthcare Platform

CVS combines insurance, pharmacy benefit management, retail dispensing and clinical care within one platform. This breadth can support member engagement, utilization steering and cross-selling, while scale in purchasing and contracting may reinforce its competitive position over the next several quarters.

Strong Cash Generation

Robust operating and free cash flow provides meaningful internal funding for debt reduction, dividends, technology investment and strategic execution. Strong cash conversion also gives CVS greater resilience when medical costs rise or operating conditions require additional investment.

Improving Earnings Outlook

Higher 2026 guidance and a further 2027 earnings floor indicate improving operating momentum across the business. Management also expects mid-teens adjusted EPS growth through 2028, suggesting the recovery is intended to extend beyond a single reporting period.

Bears Say

Thin Profitability

Low current margins leave CVS with limited tolerance for reimbursement pressure, medical-cost inflation or unfavorable business mix. Although earnings have rebounded, profitability remains below earlier periods, making sustained margin improvement important to preserve long-term earnings quality.

Meaningful Debt Burden

CVS has improved leverage from the prior year, but its debt remains substantial relative to equity. This balance-sheet burden can constrain capital allocation and financial flexibility, particularly if operating pressures persist or separation-related spending competes with deleveraging.

Healthcare Cost And Membership Headwinds

Elevated medical trends can pressure Health Care Benefits margins, while lower Caremark membership and 340B contraction may reduce Health Services earnings. Management expects stabilization, but these pressures create a material near-term test for the recovery and growth outlook.

CVS Health News

0HRS FAQ

What was CVS Health’s price range in the past 12 months?
CVS Health lowest share price was $69.18 and its highest was $112.00 in the past 12 months.
What is CVS Health’s market cap?
CVS Health’s market cap is $109.79B.
When is CVS Health’s upcoming earnings report date?
CVS Health’s next earnings report is estimated for Feb 17, 2027 (not yet confirmed), which is in 90 days.
How were CVS Health’s earnings last quarter?
CVS Health released its earnings results on Nov 04, 2026. The company reported $2.09 earnings per share for the quarter, beating the consensus estimate of $1.651 by $0.439.
Is CVS Health overvalued?
According to Wall Street analysts CVS Health’s price is currently Undervalued.
Does CVS Health pay dividends?
CVS Health pays a quarterly dividend of $0.665 which represents an annual dividend yield of 3.08%. See more information on CVS Health dividends here
What is CVS Health’s EPS estimate?
CVS Health’s EPS estimate is 1.06.
How many shares outstanding does CVS Health have?
CVS Health has 1,279,474,200 shares outstanding.
What happened to CVS Health’s price movement after its last earnings report?
CVS Health reported an EPS of $2.09 in its last earnings report, beating expectations of $1.651. Following the earnings report the stock price went down -10.954%.
Which hedge fund is a major shareholder of CVS Health?
Hedge funds hold CVS Health shares: the largest hedge-fund position in CVS Health is 1,883,905 shares, and hedge funds decreased their holdings by 6.3M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology